| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,713 |
1,529 |
$110K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
224 |
156 |
$27K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
93 |
92 |
$15K |
| 80053 |
Comprehensive metabolic panel |
529 |
488 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
24 |
24 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
65 |
58 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
576 |
539 |
$4K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
65 |
53 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
43 |
39 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
39 |
39 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
58 |
56 |
$747.70 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
747 |
202 |
$358.59 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
27 |
27 |
$336.45 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
26 |
24 |
$301.49 |
| 80061 |
Lipid panel |
15 |
15 |
$252.90 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12 |
12 |
$142.68 |
| 87081 |
|
12 |
12 |
$136.60 |
| 71045 |
Radiologic examination, chest; single view |
12 |
12 |
$106.87 |
| 36415 |
Collection of venous blood by venipuncture |
1,072 |
930 |
$58.40 |
| 81003 |
|
20 |
19 |
$53.75 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19 |
16 |
$40.84 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
220 |
78 |
$8.93 |
| A9270 |
Non-covered item or service |
68 |
44 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
47 |
25 |
$0.00 |
| 90694 |
|
19 |
15 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
19 |
15 |
$0.00 |